Vinati Organics Q3 Review - Integrating Operations With A Synergistic Amalgamation On Cards: Dolat Capital
Control raw material samples sit inside conical vials in a research laboratory.(Photographer Angel Garcia/Bloomberg)

Vinati Organics Q3 Review - Integrating Operations With A Synergistic Amalgamation On Cards: Dolat Capital

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Dolat Capital Report

Vinati Organic Ltd.’s Q3 FY21 performance continued to be muted. Sales de-grew by 6.3% YoY to Rs 2.23 billion (our estimate Rs 2.32 billion).

Ebitda de-growth stood at 13.1% YoY to Rs 721 million, with Ebitda margin contraction of 250 basis points YoY to 32.3%.

Profit after tax de-grew by 4.0% YoY to Rs 641 million.

The company got a tax benefit of Rs 110 million for Q3 FY21 and Rs 172 million for nine months FY21, due to income tax adjustments from previous years, due to which profit after tax stood at Rs 641 million, down by 4.0% YoY.

Click on the attachment to read the full report:

Dolat Capital Vinati Organics Q3FY21 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.